Guest Host: Steve Roberts

A new study suggests antidepressants may be no more effective than placebo in all but severe cases of depression. A look at how drug effectiveness is measured and weighed against safety concerns in and beyond the drug approval process.

Guests

  • Dr. William Potter serves on the FDA's Psychopharmacologic Drugs Advisory Committee, vice president for translational neuroscience at Merck Research Laboratories; board-certified psychiatrist
  • Dr. Jerry Avorn Professor of Medicine at Harvard Medical School; Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital; author "Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs"
  • Blair Johnson professor of psychology, University of Connecticut; coauthor on new antidepressant study
  • Gardiner Harris science reporter for "The New York Times"

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

David Brooks: “The Road To Character”

Thursday, Apr 16 2015New York Times Columnist David Brooks says American culture’s obsession with individual achievement and self-worth has gone too far. In a new book, he argues it is time to rethink what makes a fulfilling life and become more humble, kind and self-sacrificing.

The First Hundred Days Of The Republican-Led Congress

Thursday, Apr 16 2015Congress has reached agreement on oversight of the Iran nuclear deal and a Medicare "doc fix," and is working on fast-track trade authority for President Barack Obama. A hundred days into the new Republican-led Congress, we look at what’s been accomplished and what’s to come.